SuppreMol specializes in the development of novel therapies for autoimmune diseases and was founded in 2002 as a spin-off of the Max Planck Institute of Biochemistry.
Address
Am Klopferspitz 19a
82152 Martinsried
Info & contact
Telefon: 089 / 30 90 50 680
In portfolio
24.05.2006 – 04.03.2015
Investment manager
Thomas Manitta
